Link Pharma Chem Limited is an Indian public limited company headquartered in **Vadodara, Gujarat**, specializing in the manufacturing and sale of **organic intermediates**. The company serves a diverse global client base across the **Pharmaceutical, Agricultural, Cosmetic, and Veterinary** industries. Operating from a strategic industrial hub, the company is currently undergoing a portfolio transition toward **Specialty Chemicals** to enhance margins and mitigate the impact of volatile raw material costs. --- ### **Core Manufacturing Operations & Infrastructure** The company’s operations are centralized at a single reportable segment: **"Manufacture and Sale of Chemicals."** * **Strategic Location:** The primary manufacturing facility is located at **Plot No. 162, G.I.D.C., Nandesari, Vadodara**. * **Capacity Expansion:** In **March 2024**, the company expanded its physical footprint by acquiring **Plot No. 161** (measuring **796.75 sq. mtrs**) from Chloro Chem of India. This acquisition is intended to facilitate increased manufacturing throughput and support the development of new product lines. * **Asset Lifecycle Management:** Due to the highly corrosive nature of chemical manufacturing, the company maintains a rigorous capital expenditure program for the regular replacement of **old machinery and equipment**. Physical verification of property, plant, and equipment is conducted on a **three-year phased cycle**. --- ### **Financial Performance & Revenue Concentration** Link Pharma Chem has faced a challenging macro environment characterized by sluggish demand and stiff competition, reflected in recent revenue trends. **Revenue and Growth Trends:** | Metric | FY 2024-25 | FY 2023-24 | FY 2022-23 | |:---|:---:|:---:|:---:| | **Total Sales (Rs. Lacs)** | **2,543.34** | **2,989.77** | **3,875.78** | | **Revenue Growth (YoY)** | **-14.9%** | **-22.8%** | **-27.6%** | | **Export Revenue** | **NIL** | **NIL** | **NIL** | **Customer Concentration Risk:** The company’s revenue profile is highly concentrated among a few key players. In **FY25**, **5 customers** accounted for more than **10%** of total revenue each, contributing a combined **Rs. 18.02 crore**. This represents a broadening of the client base compared to **FY24** (where **3 customers** contributed **Rs. 13.8 crore**) but remains a significant risk factor compared to **FY23**, where just **2 customers** accounted for **Rs. 28.55 crore**. --- ### **Strategic Pivot: Specialty Chemicals & R&D** To counter declining revenues in traditional intermediates, management is executing a strategic shift: * **Product Diversification:** Active development of **new molecules** is underway to address market demand gaps. * **Margin Expansion:** The company is transitioning its portfolio toward **Specialty Chemicals**, which offer a superior margin profile compared to bulk organic intermediates. * **Leadership Expertise:** The strategy is spearheaded by **Mr. Rishikesh Thakur (MD)**, who brings over **12 years** of experience in R&D and project development, supported by **Mr. Satish G. Thakur (Chairman & WTD)**. --- ### **Sustainability & Environmental Governance** Operating in a strictly regulated sector, the company has integrated environmental compliance into its operational framework. * **Regulatory Recovery:** Following a closure order from the **Gujarat Pollution Control Board (GPCB)** in **July 2023**, the company successfully implemented corrective measures and secured a **revocation of the order**. * **Emission Controls:** The facility utilizes a **dilute caustic scrubber** and mist eliminator to manage sulphur dioxide emissions. * **Resource Efficiency:** * **Energy:** Utilization of **waste heat energy** via economizers and **frequency control devices** for exhaust fans. * **Water/Steam:** Implementation of **closed-loop systems** for steam condensate recycling and resource recovery. * **Lighting:** Transition to **LED lighting** and power-saver devices across the plant. --- ### **Liquidity, Capital, and Risk Management** The company maintains a conservative financial profile, relying primarily on internal accruals and structured credit lines. **Working Capital Management (₹ in Lakhs):** | Particulars | As at March 31, 2025 | As at March 31, 2024 | | :--- | :---: | :---: | | **Amount Used** | **512.28** | **781.78** | | **Amount Unused** | **287.72** | **18.22** | * **Credit Risk Mitigation:** The company employs a **Life Time Expected Credit Loss (ECL)** model. To protect against defaults, it maintains a **Credit Insurance Policy** covering both domestic and export receivables. * **Investment Policy:** Surplus funds are allocated to **Liquid/Short Term Mutual Funds** and high-rated **Bank Deposits**. Under **Ind AS 109**, these are valued at market prices, with fluctuations recorded in the P&L (Other Income). * **Market Risks:** While the company has **no significant interest rate risk** (due to a lack of long-term borrowings), it remains exposed to **raw material volatility**, specifically petroleum and natural gas derivatives (crude oil and solvents). --- ### **Regulatory, Legal, and Governance Updates** * **Taxation:** The company is currently contesting a **demand order** from the **Assistant Commissioner, Central GST & Central Excise, Vadodara** for GST, interest, and penalties (reported Jan 2026). * **Labor Compliance:** Following the implementation of the **four Labour Codes** in **November 2025**, the company has made necessary provisions as of **Q3 FY26**, concluding there is currently **no material financial impact**. * **Shareholding:** A request to reclassify a shareholder from **'Promoter Group'** to **'Public'** was **rejected by BSE Limited** in February 2025. * **Administrative:** The Registrar and Transfer Agent (RTA) was updated to **MUFG Intime India Private Limited** in December 2024.